Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD

NCT01820832 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT01820832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01820832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD
Lead sponsor
Huashan Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2013
Completion date
June 30, 2015
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, proteinuria